116 related articles for article (PubMed ID: 11287752)
21. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
[TBL] [Abstract][Full Text] [Related]
22. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
[TBL] [Abstract][Full Text] [Related]
23. Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies.
Pollock NI; Wang L; Wallweber G; Gooding WE; Huang W; Chenna A; Winslow J; Sen M; DeGrave KA; Li H; Zeng Y; Grandis JR
Clin Cancer Res; 2015 Oct; 21(20):4597-606. PubMed ID: 26138066
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus type 16 E5 protein as a therapeutic target.
Kim SW; Yang JS
Yonsei Med J; 2006 Feb; 47(1):1-14. PubMed ID: 16502480
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5.
Trammel J; Amusan O; Hultgren A; Raikhy G; Bodily JM
Virology; 2024 Feb; 590():109952. PubMed ID: 38103269
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
[TBL] [Abstract][Full Text] [Related]
27. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
29. Increased angiogenesis in the uterine cervix associated with human papillomavirus infection.
Nair P; Gangadevi T; Jayaprakash PG; Nair MB; Nair MK; Pillai MR
Pathol Res Pract; 1999; 195(3):163-9. PubMed ID: 10220796
[TBL] [Abstract][Full Text] [Related]
30. Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer.
Hemmat N; Doustvandi MA; Asadzadeh Z; Mokhtarzadeh A; Baradaran B; Baghi HB
Oncol Res; 2021; 29(2):141-148. PubMed ID: 37305401
[TBL] [Abstract][Full Text] [Related]
31. EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM.
Chantima W; Thepthai C; Cheunsuchon P; Dharakul T
BMC Cancer; 2017 Dec; 17(1):811. PubMed ID: 29202724
[TBL] [Abstract][Full Text] [Related]
32. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
33. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides.
Kell B; Jewers RJ; Cason J; Pakarian F; Kaye JN; Best JM
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2451-6. PubMed ID: 8077947
[TBL] [Abstract][Full Text] [Related]
34. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?
Suprynowicz FA; Disbrow GL; Simic V; Schlegel R
Virology; 2005 Feb; 332(1):102-13. PubMed ID: 15661144
[TBL] [Abstract][Full Text] [Related]
35. [Expression of human papillomavirus 16, 18 E6 protein of cervical squamous cell carcinoma].
Ren Z; Shi Z; Chen W
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):161-2. PubMed ID: 10072859
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
37. The biochemical and biological functions of human papillomavirus type 16 E5 protein.
Tsai TC; Chen SL
Arch Virol; 2003 Aug; 148(8):1445-53. PubMed ID: 12898324
[TBL] [Abstract][Full Text] [Related]
38. E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
Iancu IV; Pleşa A; Botezatu A; Huică I; Stănescu AD; Socolov D; Anton G
Roum Arch Microbiol Immunol; 2015; 74(1-2):33-9. PubMed ID: 26727852
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Cortelazzi B; Verderio P; Ciniselli CM; Pizzamiglio S; Bossi P; Gloghini A; Gualeni AV; Volpi CC; Locati L; Pierotti MA; Licitra L; Pilotti S; Perrone F
J Oral Pathol Med; 2015 Oct; 44(9):734-45. PubMed ID: 25495427
[TBL] [Abstract][Full Text] [Related]
40. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
